RPC
QNTM

Rossmore Private Capital’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

Rossmore Private Capital’s Portfolio QNTM Stock Details QNTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-354
Closed -$40K – 227
2021
Q2 		$40K Hold
354
– – 0.01% 222
2021
Q1 		$44K Hold
354
– – 0.01% 213
2020
Q4 		$36K Buy
+354
New +$41.8K 0.01% 198

Other funds holding QNTM

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VIA
Vident Investment Advisory Alpharetta, Georgia $2.9B AUM 24.67% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
RM
Resource Management Metairie, Louisiana $970M AUM 28.05% 1-Year Est. Return
Wolverine Trading
Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Rossmore Private Capital's QNTM Position: Q3 2021 in Review

Rossmore Private Capital sold out of Quantum Biopharma Class B Subordinate Voting Shares (QNTM) in Q3 2021, closing a stake of 354 shares — an estimated $40K sold.

Rossmore Private Capital first reported a position in QNTM in Q4 2020 and held it in 3 quarters. The position peaked at $44K in Q1 2021. 17 funds tracked by Wall St. Rank hold QNTM as of Q3 2021.

  • Rossmore Private Capital reported no remaining Quantum Biopharma Class B Subordinate Voting Shares position as of Q3 2021 after selling out during the quarter.
  • Rossmore Private Capital sold 354 Quantum Biopharma Class B Subordinate Voting Shares shares in Q3 2021, an estimated $40K.
  • Rossmore Private Capital first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q4 2020 and held it in 3 quarters.
  • Rossmore Private Capital's Quantum Biopharma Class B Subordinate Voting Shares position peaked at $44K in Q1 2021.
  • 17 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q3 2021.

Based on Rossmore Private Capital's 13F filing for Q3 2021, filed 8 Nov 2021.